| 10098667
|
Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
1999 |
Venkatraman S;Kong J;Nimkar S;Wang QM;Aube J;Hanzlik RP |
View
More |
| 10197964
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Fuhrman SA;Patick AK;Matthews DA;Ford CE;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 10197965
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Webber SE;Marakovits JT;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Ford CE;Burke BJ;Rejto PA;Hendrickson TF;Tuntland T;Brown EL;Meador JW 3rd;Ferre RA;Harr JE;Kosa MB;Worland ST |
View
More |
| 10224078
|
Identification and characterization of human rhinovirus-14 3C protease deamidation isoform. |
J Biol Chem |
1999 |
Cox GA;Johnson RB;Cook JA;Wakulchik M;Johnson MG;Villarreal EC;Wang QM |
View
More |
| 10353638
|
Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides. |
Bioorg Med Chem |
1999 |
Dragovich PS;Zhou R;Skalitzky DJ;Fuhrman SA;Patick AK;Ford CE;Meador JW 3rd;Worland ST |
View
More |
| 10396129
|
Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. |
Prog Drug Res |
1999 |
Wang QM |
View
More |
| 10465543
|
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. |
Bioorg Med Chem Lett |
1999 |
Dragovich PS;Webber SE;Prins TJ;Zhou R;Marakovits JT;Tikhe JG;Fuhrman SA;Patick AK;Matthews DA;Ford CE;Brown EL;Binford SL;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 10500114
|
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. |
Proc Natl Acad Sci U S A |
1999 |
Matthews DA;Dragovich PS;Webber SE;Fuhrman SA;Patick AK;Zalman LS;Hendrickson TF;Love RA;Prins TJ;Marakovits JT;Zhou R;Tikhe J;Ford CE;Meador JW;Ferre RA;Brown EL;Binford SL;Brothers MA;DeLisle DM;Worland ST |
View
More |
| 10507322
|
Rhinovirus 2A proteinase mediated stimulation of rhinovirus RNA translation is additive to the stimulation effected by cellular RNA binding proteins. |
Virus Res |
1999 |
Hunt SL;Skern T;Liebig HD;Kuechler E;Jackson RJ |
View
More |
| 10507325
|
The structures of picornaviral proteinases. |
Virus Res |
1999 |
Seipelt J;Guarne A;Bergmann E;James M;Sommergruber W;Fita I;Skern T |
View
More |
| 10508022
|
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
1999 |
Patick AK;Binford SL;Brothers MA;Jackson RL;Ford CE;Diem MD;Maldonado F;Dragovich PS;Zhou R;Prins TJ;Fuhrman SA;Meador JW;Zalman LS;Matthews DA;Worland ST |
View
More |
| 10523291
|
The structure of the 2A proteinase from a common cold virus: a proteinase responsible for the shut-off of host-cell protein synthesis. |
EMBO J |
1999 |
Petersen JF;Cherney MM;Liebig HD;Skern T;Kuechler E;James MN |
View
More |
| 10590122
|
A cysteine-rich motif in poliovirus protein 2C(ATPase) is involved in RNA replication and binds zinc in vitro. |
J Virol |
2000 |
Pfister T;Jones KW;Wimmer E |
View
More |
| 10636240
|
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2000 |
Dragovich PS;Zhou R;Webber SE;Prins TJ;Kwok AK;Okano K;Fuhrman SA;Zalman LS;Maldonado FC;Brown EL;Meador JW 3rd;Patick AK;Ford CE;Brothers MA;Binford SL;Matthews DA;Ferre RA;Worland ST |
View
More |
| 10640559
|
The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation. |
J Gen Virol |
2000 |
Hughes PJ;Stanway G |
View
More |
| 10770757
|
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. |
Antimicrob Agents Chemother |
2000 |
Zalman LS;Brothers MA;Dragovich PS;Zhou R;Prins TJ;Worland ST;Patick AK |
View
More |
| 10794684
|
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation. |
J Med Chem |
2000 |
Reich SH;Johnson T;Wallace MB;Kephart SE;Fuhrman SA;Worland ST;Matthews DA;Hendrickson TF;Chan F;Meador J 3rd;Ferre RA;Brown EL;DeLisle DM;Patick AK;Binford SL;Ford CE |
View
More |
| 10867028
|
2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. |
J Biol Chem |
2000 |
Seipelt J;Liebig HD;Sommergruber W;Gerner C;Kuechler E |
View
More |
| 10950388
|
Antiviral therapy for enteroviruses and rhinoviruses. |
Antivir Chem Chemother |
2000 |
Rotbart HA |
View
More |
| 10999479
|
S-nitrosothiols as novel, reversible inhibitors of human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2000 |
Xian M;Wang QM;Chen X;Wang K;Wang PG |
View
More |
| 11007981
|
Characterization of the active site thiol group of rhinovirus 2A proteinase. |
FEBS Lett |
2000 |
Sarkany Z;Skern T;Polgar L |
View
More |
| 11034318
|
Extremely efficient cleavage of eIF4G by picornaviral proteinases L and 2A in vitro. |
FEBS Lett |
2000 |
Glaser W;Skern T |
View
More |
| 11118371
|
Complete nucleotide sequence of the chiba virus genome and functional expression of the 3C-like protease in Escherichia coli. |
Virology |
2000 |
Someya Y;Takeda N;Miyamura T |
View
More |
| 11161279
|
The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage. |
J Gen Virol |
2001 |
Li X;Lu HH;Mueller S;Wimmer E |
View
More |
| 11162821
|
Activation of human rhinovirus-14 3C protease. |
Virology |
2001 |
Wang QM;Johnson RB |
View
More |
| 11166856
|
The treatment of rhinovirus infections: progress and potential. |
Antiviral Res |
2001 |
Turner RB |
View
More |
| 11274152
|
Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. |
J Biol Chem |
2001 |
Bushell M;Wood W;Carpenter G;Pain VM;Morley SJ;Clemens MJ |
View
More |
| 11302940
|
Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease. |
Drug Metab Dispos |
2001 |
Zhang KE;Hee B;Lee CA;Liang B;Potts BC |
View
More |
| 11367747
|
[Effect of activities of vagi and sympathetic nervous system on heart rate variability]. |
Sheng Li Xue Bao |
1998 |
Li L;Zhu JW;Cao YX;Li P |
View
More |
| 11378491
|
Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces. |
J Clin Virol |
2001 |
Ostroff R;Ettinger A;La H;Rihanek M;Zalman L;Meador J 3rd;Patick AK;Worland S;Polisky B |
View
More |
| 11414203
|
MBP fusion protein with a viral protease cleavage site: one-step cleavage/purification of insoluble proteins. |
Biotechniques |
2001 |
Alexandrov A;Dutta K;Pascal SM |
View
More |
| 11548209
|
Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. |
Prog Drug Res |
2001 |
Wang QM |
View
More |
| 11591501
|
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2001 |
Webber SE;Marakovits JT;Dragovich PS;Prins TJ;Zhou R;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Srinivasan B;Moran T;Ford CE;Brothers MA;Harr JE;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 11713272
|
Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. |
Mol Cell Biol |
2001 |
Kruger M;Beger C;Welch PJ;Barber JR;Manns MP;Wong-Staal F |
View
More |
| 11720861
|
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues. |
Bioorg Med Chem Lett |
2001 |
Singh SB;Graham PL;Reamer RA;Cordingley MG |
View
More |
| 11858991
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics. |
Bioorg Med Chem Lett |
2002 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Hou X;Meador JW;Ferre RA;Worland ST |
View
More |
| 11865407
|
Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. |
J Infect Dis |
2002 |
Seymour ML;Gilby N;Bardin PG;Fraenkel DJ;Sanderson G;Penrose JF;Holgate ST;Johnston SL;Sampson AP |
View
More |
| 11900346
|
Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing. |
Antivir Chem Chemother |
2001 |
Murray MA;Janc JW;Venkatraman S;Babe LM |
View
More |
| 11911365
|
Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C. |
RNA |
2002 |
Zell R;Sidigi K;Bucci E;Stelzner A;Gorlach M |
View
More |
| 11931615
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics. |
J Med Chem |
2002 |
Dragovich PS;Prins TJ;Zhou R;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Tuntland T;Lee CA;Patick AK;Matthews DA;Hendrickson TF;Kosa MB;Liu B;Batugo MR;Gleeson JP;Sakata SK;Chen L;Guzman MC;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 11966457
|
Thiol-dependent enzymes and their inhibitors: a review. |
Curr Med Chem |
2002 |
Leung-Toung R;Li W;Tam TF;Karimian K |
View
More |
| 11985469
|
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease. |
J Med Chem |
2002 |
Johnson TO;Hua Y;Luu HT;Brown EL;Chan F;Chu SS;Dragovich PS;Eastman BW;Ferre RA;Fuhrman SA;Hendrickson TF;Maldonado FC;Matthews DA;Meador JW 3rd;Patick AK;Reich SH;Skalitzky DJ;Worland ST;Yang M;Zalman LS |
View
More |
| 12133721
|
Recent advances in the synthesis, design and selection of cysteine protease inhibitors. |
Curr Opin Chem Biol |
2002 |
Hernandez AA;Roush WR |
View
More |
| 12228254
|
Recognition of eukaryotic initiation factor 4G isoforms by picornaviral proteinases. |
J Biol Chem |
2002 |
Foeger N;Glaser W;Skern T |
View
More |
| 12370021
|
Inhibition of cysteine protease activity by NO-donors. |
Curr Protein Pept Sci |
2001 |
Ascenzi P;Salvati L;Bolognesi M;Colasanti M;Polticelli F;Venturini G |
View
More |
| 12525179
|
The unusual catalytic triad of poliovirus protease 3C. |
Biochemistry |
2003 |
Sarkany Z;Polgar L |
View
More |
| 12653165
|
Increased aeroallergen-specific interleukin-4-producing T cells in asthmatic adults. |
Clin Exp Allergy |
2002 |
Pala P;Message SD;Johnston SL;Openshaw PJ |
View
More |
| 12663811
|
The processing of eIF4GI by human rhinovirus type 2 2A(pro): relationship to self-cleavage and role of zinc. |
J Virol |
2003 |
Glaser W;Triendl A;Skern T |
View
More |
| 12663812
|
Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different. |
J Virol |
2003 |
Gradi A;Svitkin YV;Sommergruber W;Imataka H;Morino S;Skern T;Sonenberg N |
View
More |
| 12746549
|
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. |
Science |
2003 |
Anand K;Ziebuhr J;Wadhwani P;Mesters JR;Hilgenfeld R |
View
More |
| 12766405
|
Backbone 1H, 15N and 13C assignments for the human rhinovirus 3C protease (serotype 14). |
J Biomol NMR |
2003 |
Bjorndahl TC;Monzavi H;Wishart DS |
View
More |
| 12791690
|
Human rhinovirus 2 2Apro recognition of eukaryotic initiation factor 4GI. Involvement of an exosite. |
J Biol Chem |
2003 |
Foeger N;Schmid EM;Skern T |
View
More |
| 12921996
|
Encephalomyocarditis virus (EMCV) proteins 2A and 3BCD localize to nuclei and inhibit cellular mRNA transcription but not rRNA transcription. |
Virus Res |
2003 |
Aminev AG;Amineva SP;Palmenberg AC |
View
More |
| 1310193
|
Characterization of the roles of conserved cysteine and histidine residues in poliovirus 2A protease. |
Virology |
1992 |
Yu SF;Lloyd RE |
View
More |
| 1316450
|
Determinants of substrate recognition by poliovirus 2A proteinase. |
J Virol |
1992 |
Hellen CU;Lee CK;Wimmer E |
View
More |
| 1325156
|
Using proteinase trapping to detect revertants of inactive rhinoviral 2A proteinase mutants. |
Biol Chem Hoppe Seyler |
1992 |
Luderer M;Liebig HD;Sommergruber W;Blaas D;Kuechler E;Skern T |
View
More |
| 1331062
|
Cleavage specificity on synthetic peptide substrates of human rhinovirus 2 proteinase 2A. |
J Biol Chem |
1992 |
Sommergruber W;Ahorn H;Zophel A;Maurer-Fogy I;Fessl F;Schnorrenberg G;Liebig HD;Blaas D;Kuechler E;Skern T |
View
More |
| 14505664
|
Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2003 |
Chen SH;Lamar J;Victor F;Snyder N;Johnson R;Heinz BA;Wakulchik M;Wang QM |
View
More |
| 14521419
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. |
J Med Chem |
2003 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Hua Y;Luu HT;Sakata SK;Brown EL;Maldonado FC;Tuntland T;Lee CA;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Wu EY;Guo M;Borer BC;Nayyar NK;Moran T;Chen L;Rejto PA;Rose PW;Guzman MC;Dovalsantos EZ;Lee S;McGee K;Mohajeri M;Liese A;Tao J;Kosa MB;Liu B;Batugo MR;Gleeson JP;Wu ZP;Liu J;Meador JW 3rd;Ferre RA |
View
More |
| 14605258
|
Rhinovirus 16 3C protease induces interleukin-8 and granulocyte-macrophage colony-stimulating factor expression in human bronchial epithelial cells. |
Pediatr Res |
2004 |
Funkhouser AW;Kang JA;Tan A;Li J;Zhou L;Abe MK;Solway J;Hershenson MB |
View
More |
| 15003865
|
NuMA and nuclear lamins are cleaved during viral infection--inhibition of caspase activity prevents cleavage and rescues HeLa cells from measles virus-induced but not from rhinovirus 1B-induced cell death. |
Virology |
2004 |
Taimen P;Berghall H;Vainionpaa R;Kallajoki M |
View
More |
| 15080921
|
Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design. |
Bioorg Med Chem |
2004 |
Zhang XW;Yap YL |
View
More |
| 15168795
|
An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents. |
Antiviral Res |
2004 |
Ettinger A;Ostroff R;Rhihanek M;Dragovich PS;Zalman LS;Patick AK;Prins TJ;Fuhrman SA;Brown EL;Worland ST;Polisky B |
View
More |
| 15320724
|
Inhibitors of 3C cysteine proteinases from Picornaviridae. |
Curr Top Med Chem |
2004 |
Lall MS;Jain RP;Vederas JC |
View
More |
| 15448360
|
Rhinovirus 3C protease precursors 3CD and 3CD\' localize to the nuclei of infected cells. |
J Gen Virol |
2004 |
Amineva SP;Aminev AG;Palmenberg AC;Gern JE |
View
More |
| 15673742
|
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. |
Antimicrob Agents Chemother |
2005 |
Binford SL;Maldonado F;Brothers MA;Weady PT;Zalman LS;Meador JW 3rd;Matthews DA;Patick AK |
View
More |
| 15722530
|
Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. |
J Gen Virol |
2005 |
Laine P;Savolainen C;Blomqvist S;Hovi T |
View
More |
| 15814817
|
A novel cGUUAg tetraloop structure with a conserved yYNMGg-type backbone conformation from cloverleaf 1 of bovine enterovirus 1 RNA. |
Nucleic Acids Res |
2005 |
Ihle Y;Ohlenschlager O;Hafner S;Duchardt E;Zacharias M;Seitz S;Zell R;Ramachandran R;Gorlach M |
View
More |
| 15917520
|
In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
2005 |
Patick AK;Brothers MA;Maldonado F;Binford S;Maldonado O;Fuhrman S;Petersen A;Smith GJ 3rd;Zalman LS;Burns-Naas LA;Tran JQ |
View
More |
| 16279553
|
[Rhinovirus diseases: pathogenesis, diagnostics and treatment]. |
Zh Mikrobiol Epidemiol Immunobiol |
2005 |
Faizuloev EB;Nikonova AA;Zverev VV |
View
More |
| 16415022
|
Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease. |
J Virol |
2006 |
Baxter NJ;Roetzer A;Liebig HD;Sedelnikova SE;Hounslow AM;Skern T;Waltho JP |
View
More |
| 16510461
|
Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells. |
Eur Respir J |
2006 |
Yasuda H;Yamaya M;Sasaki T;Inoue D;Nakayama K;Yamada M;Asada M;Yoshida M;Suzuki T;Nishimura H;Sasaki H |
View
More |
| 1653490
|
Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli. |
Virology |
1991 |
Aschauer B;Werner G;McCray J;Rosenwirth B;Bachmayer H |
View
More |
| 1654789
|
Development of synthetic peptide substrates for the poliovirus 3C proteinase. |
Arch Biochem Biophys |
1991 |
Weidner JR;Dunn BM |
View
More |
| 1658106
|
Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay. |
J Biochem Biophys Methods |
1991 |
Hopkins JL;Betageri R;Cohen KA;Emmanuel MJ;Joseph CR;Bax PM;Pallai PV;Skoog MT |
View
More |
| 16759084
|
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. |
J Med Chem |
2006 |
Zhou L;Liu Y;Zhang W;Wei P;Huang C;Pei J;Yuan Y;Lai L |
View
More |
| 16973565
|
An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases. |
J Virol |
2006 |
Deszcz L;Cencic R;Sousa C;Kuechler E;Skern T |
View
More |
| 17007846
|
Defining residues involved in human rhinovirus 2A proteinase substrate recognition. |
FEBS Lett |
2006 |
Sousa C;Schmid EM;Skern T |
View
More |
| 17267501
|
MDA-5 is cleaved in poliovirus-infected cells. |
J Virol |
2007 |
Barral PM;Morrison JM;Drahos J;Gupta P;Sarkar D;Fisher PB;Racaniello VR |
View
More |
| 17305557
|
Human rhinovirus 3C protease as a potential target for the development of antiviral agents. |
Curr Protein Pept Sci |
2007 |
Wanga QM;Chen SH |
View
More |
| 17374764
|
PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. |
J Gen Virol |
2007 |
Lanke K;Krenn BM;Melchers WJG;Seipelt J;van Kuppeveld FJM |
View
More |
| 17395640
|
The leader region of Laminin B1 mRNA confers cap-independent translation. |
Nucleic Acids Res |
2007 |
Petz M;Kozina D;Huber H;Siwiec T;Seipelt J;Sommergruber W;Mikulits W |
View
More |
| 17485072
|
Development of potent inhibitors of the coxsackievirus 3C protease. |
Biochem Biophys Res Commun |
2007 |
Lee ES;Lee WG;Yun SH;Rho SH;Im I;Yang ST;Sellamuthu S;Lee YJ;Kwon SJ;Park OK;Jeon ES;Park WJ;Kim YC |
View
More |
| 17908951
|
In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
2007 |
Binford SL;Weady PT;Maldonado F;Brothers MA;Matthews DA;Patick AK |
View
More |
| 17944485
|
NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison. |
Biochemistry |
2007 |
Bjorndahl TC;Andrew LC;Semenchenko V;Wishart DS |
View
More |
| 18248816
|
New anti-viral drugs for the treatment of the common cold. |
Bioorg Med Chem |
2008 |
Maugeri C;Alisi MA;Apicella C;Cellai L;Dragone P;Fioravanzo E;Florio S;Furlotti G;Mangano G;Ombrato R;Luisi R;Pompei R;Rincicotti V;Russo V;Vitiello M;Cazzolla N |
View
More |
| 1847268
|
Substrate requirements of a human rhinoviral 2A proteinase. |
Virology |
1991 |
Skern T;Sommergruber W;Auer H;Volkmann P;Zorn M;Liebig HD;Fessl F;Blaas D;Kuechler E |
View
More |
| 18572216
|
Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. |
Virology |
2008 |
de Breyne S;Bonderoff JM;Chumakov KM;Lloyd RE;Hellen CU |
View
More |
| 18583140
|
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. |
Bioorg Med Chem |
2008 |
Kuo CJ;Shie JJ;Fang JM;Yen GR;Hsu JT;Liu HG;Tseng SN;Chang SC;Lee CY;Shih SR;Liang PH |
View
More |
| 18647315
|
Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. |
Clin Exp Allergy |
2008 |
Bossios A;Gourgiotis D;Skevaki CL;Saxoni-Papageorgiou P;Lotvall J;Psarras S;Karpathios T;Constandopoulos AG;Johnston SL;Papadopoulos NG |
View
More |
| 19048198
|
Viral protease inhibitors. |
Handb Exp Pharmacol |
2009 |
Anderson J;Schiffer C;Lee SK;Swanstrom R |
View
More |
| 19211759
|
Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. |
J Virol |
2009 |
Morrison JM;Racaniello VR |
View
More |
| 19268541
|
A picornaviral loop-to-loop replication complex. |
J Struct Biol |
2009 |
Claridge JK;Headey SJ;Chow JY;Schwalbe M;Edwards PJ;Jeffries CM;Venugopal H;Trewhella J;Pascal SM |
View
More |
| 19333433
|
Over-expression, rapid preparation and some properties of c-terminal BARc region in PICK1. |
Int J Mol Sci |
2009 |
Xiao H;Shi Y;Yuan J;Huang Y;Wang J |
View
More |
| 19403669
|
Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. |
J Virol |
2009 |
Ghildyal R;Jordan B;Li D;Dagher H;Bardin PG;Gern JE;Jans DA |
View
More |
| 19457455
|
Robust production of a peptide library using methodological synchronization. |
Protein Expr Purif |
2009 |
Huber KL;Olson KD;Hardy JA |
View
More |
| 19464175
|
Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2009 |
Im I;Lee ES;Choi SJ;Lee JY;Kim YC |
View
More |
| 19628239
|
RIG-I is cleaved during picornavirus infection. |
Virology |
2009 |
Barral PM;Sarkar D;Fisher PB;Racaniello VR |
View
More |
| 20021285
|
Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors. |
Expert Opin Ther Pat |
2010 |
Wang HM;Liang PH |
View
More |
| 20066739
|
Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. |
World J Gastroenterol |
2010 |
Zhang XN;Song ZG;Jiang T;Shi BS;Hu YW;Yuan ZH |
View
More |
| 20430426
|
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. |
J Allergy Clin Immunol |
2010 |
Singh M;Lee SH;Porter P;Xu C;Ohno A;Atmar RL;Greenberg SB;Bandi V;Gern J;Amineva S;Aminev A;Skern T;Smithwick P;Perusich S;Barrow N;Roberts L;Corry DB;Kheradmand F |
View
More |
| 20622012
|
Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease. |
J Biol Chem |
2010 |
Park N;Skern T;Gustin KE |
View
More |
| 20713300
|
Are rhinoviral proteinases responsible for mixed T(H)1 and T(H)2 immunity in chronic obstructive pulmonary disease? |
J Allergy Clin Immunol |
2010 |
Upham JW;Pritchard A |
View
More |
| 21183345
|
Non-covalent inhibitors of rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2011 |
Baxter A;Chambers M;Edfeldt F;Edman K;Freeman A;Johansson C;King S;Morley A;Petersen J;Rawlins P;Spadola L;Thong B;Van de Poel H;Williams N |
View
More |
| 21543871
|
Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor. |
Acta Crystallogr Sect F Struct Biol Cryst Commun |
2011 |
Amacher JF;Cushing PR;Weiner JA;Madden DR |
View
More |
| 2154618
|
Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A. |
J Virol |
1990 |
Jewell JE;Ball LA;Rueckert R |
View
More |
| 2158990
|
Site-directed mutagenesis suggests close functional relationship between a human rhinovirus 3C cysteine protease and cellular trypsin-like serine proteases. |
J Biol Chem |
1990 |
Cheah KC;Leong LE;Porter AG |
View
More |
| 21605680
|
Production and single-step purification of EGFP and a biotinylated version of the Human Rhinovirus 14 3C protease. |
Protein Expr Purif |
2011 |
Youell J;Fordham D;Firman K |
View
More |
| 2160953
|
Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro. |
J Biol Chem |
1990 |
Cordingley MG;Callahan PL;Sardana VV;Garsky VM;Colonno RJ |
View
More |
| 21664926
|
Homology modeling, docking, molecular dynamics simulation, and structural analyses of coxsakievirus B3 2A protease: an enzyme involved in the pathogenesis of inflammatory myocarditis. |
Int J Biol Macromol |
2011 |
Maghsoudi AH;Khodagholi F;Hadi-Alijanvand H;Esfandiarei M;Sabbaghian M;Zakeri Z;Shaerzadeh F;Abtahi S;Maghsoudi N |
View
More |
| 21795339
|
Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. |
J Virol |
2011 |
Lu G;Qi J;Chen Z;Xu X;Gao F;Lin D;Qian W;Liu H;Jiang H;Yan J;Gao GF |
View
More |
| 21813612
|
Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. |
J Virol |
2011 |
Wang J;Fan T;Yao X;Wu Z;Guo L;Lei X;Wang J;Wang M;Jin Q;Cui S |
View
More |
| 21835784
|
Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93. |
J Virol |
2011 |
Costenaro L;Kaczmarska Z;Arnan C;Janowski R;Coutard B;Sola M;Gorbalenya AE;Norder H;Canard B;Coll M |
View
More |
| 21835805
|
Differential processing of nuclear pore complex proteins by rhinovirus 2A proteases from different species and serotypes. |
J Virol |
2011 |
Watters K;Palmenberg AC |
View
More |
| 21936817
|
Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery. |
Biochem Soc Trans |
2011 |
Ramajayam R;Tan KP;Liang PH |
View
More |
| 22072773
|
Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease. |
J Virol |
2012 |
Falah N;Violot S;Decimo D;Berri F;Foucault-Grunenwald ML;Ohlmann T;Schuffenecker I;Morfin F;Lina B;Riteau B;Cortay JC |
View
More |
| 22687728
|
[Expression and role of sugar chains on airway mucus during the exacerbation of airway inflammation]. |
Yakugaku Zasshi |
2012 |
Ishibashi Y;Inouye Y;Taniguchi A |
View
More |
| 22763202
|
A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors. |
Bioorg Med Chem Lett |
2012 |
Schunemann K;Connelly S;Kowalczyk R;Sperry J;Wilson IA;Fraser JD;Brimble MA |
View
More |
| 22865380
|
Blocking human enterovirus 71 replication by targeting viral 2A protease. |
J Antimicrob Chemother |
2012 |
Falah N;Montserret R;Lelogeais V;Schuffenecker I;Lina B;Cortay JC;Violot S |
View
More |
| 23131833
|
Picornavirus modification of a host mRNA decay protein. |
mBio |
2012 |
Rozovics JM;Chase AJ;Cathcart AL;Chou W;Gershon PD;Palusa S;Wilusz J;Semler BL |
View
More |
| 23164665
|
Nickel-regulated heart rate variability: the roles of oxidative stress and inflammation. |
Toxicol Appl Pharmacol |
2013 |
Chuang HC;Hsueh TW;Chang CC;Hwang JS;Chuang KJ;Yan YH;Cheng TJ |
View
More |
| 23255796
|
Viral proteinase requirements for the nucleocytoplasmic relocalization of cellular splicing factor SRp20 during picornavirus infections. |
J Virol |
2013 |
Fitzgerald KD;Chase AJ;Cathcart AL;Tran GP;Semler BL |
View
More |
| 23300834
|
Express your LOV: an engineered flavoprotein as a reporter for protein expression and purification. |
PLoS One |
2012 |
Gawthorne JA;Reddick LE;Akpunarlieva SN;Beckham KS;Christie JM;Alto NM;Gabrielsen M;Roe AJ |
View
More |
| 23388726
|
3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. |
J Virol |
2013 |
Tan J;George S;Kusov Y;Perbandt M;Anemuller S;Mesters JR;Norder H;Coutard B;Lacroix C;Leyssen P;Neyts J;Hilgenfeld R |
View
More |
| 23395976
|
Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases. |
Anal Biochem |
2013 |
Raran-Kurussi S;Tozser J;Cherry S;Tropea JE;Waugh DS |
View
More |
| 23410102
|
A new method to customize protein expression vectors for fast, efficient and background free parallel cloning. |
BMC Biotechnol |
2013 |
Scholz J;Besir H;Strasser C;Suppmann S |
View
More |
| 23549610
|
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles\' heel": current effective inhibitor targeting a 3C-like protease. |
Protein Cell |
2013 |
Ren Z;Yan L;Zhang N;Guo Y;Yang C;Lou Z;Rao Z |
View
More |
| 23580429
|
Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. |
J Gen Virol |
2013 |
Neubauer D;Aumayr M;Gosler I;Skern T |
View
More |
| 23616646
|
Conformational plasticity of the 2A proteinase from enterovirus 71. |
J Virol |
2013 |
Cai Q;Yameen M;Liu W;Gao Z;Li Y;Peng X;Cai Y;Wu C;Zheng Q;Li J;Lin T |
View
More |
| 23633597
|
Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir. |
Acta Crystallogr D Biol Crystallogr |
2013 |
Wu C;Cai Q;Chen C;Li N;Peng X;Cai Y;Yin K;Chen X;Wang X;Zhang R;Liu L;Chen S;Li J;Lin T |
View
More |
| 23903828
|
Cellular mRNA decay protein AUF1 negatively regulates enterovirus and human rhinovirus infections. |
J Virol |
2013 |
Cathcart AL;Rozovics JM;Semler BL |
View
More |
| 23951130
|
Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells. |
PLoS One |
2013 |
Walker EJ;Younessi P;Fulcher AJ;McCuaig R;Thomas BJ;Bardin PG;Jans DA;Ghildyal R |
View
More |
| 24026848
|
An open conformation determined by a structural switch for 2A protease from coxsackievirus A16. |
Protein Cell |
2013 |
Sun Y;Wang X;Yuan S;Dang M;Li X;Zhang XC;Rao Z |
View
More |
| 24125888
|
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. |
Bioorg Med Chem Lett |
2013 |
Prior AM;Kim Y;Weerasekara S;Moroze M;Alliston KR;Uy RA;Groutas WC;Chang KO;Hua DH |
View
More |
| 24346589
|
Synthesis of the 2-methylene analogue of the HRV 3C protease inhibitor thysanone (2-carbathysanone). |
Org Biomol Chem |
2014 |
Schunemann K;Furkert DP;Choi EC;Connelly S;Fraser JD;Sperry J;Brimble MA |
View
More |
| 24649897
|
A new fusion protein platform for quantitatively measuring activity of multiple proteases. |
Microb Cell Fact |
2014 |
Zhou C;Yan Y;Fang J;Cheng B;Fan J |
View
More |
| 24727155
|
A novel self-cleavage system for production of soluble recombinant protein in Escherichia coli. |
Protein Expr Purif |
2014 |
Feng Y;Xu Q;Yang T;Sun E;Li J;Shi D;Wu D |
View
More |
| 24846903
|
Plasma vitamin B12, methylmalonic acid and heart rate variability in healthy young Indian adults. |
Int J Vitam Nutr Res |
2013 |
Sucharita S;Sowmya S;Thomas T;Kurpad AV;Vaz M |
View
More |
| 24870364
|
A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases. |
J Med Chem |
2014 |
Kathman SG;Xu Z;Statsyuk AV |
View
More |
| 24937088
|
Solution structure of the 2A protease from a common cold agent, human rhinovirus C2, strain W12. |
PLoS One |
2014 |
Lee W;Watters KE;Troupis AT;Reinen NM;Suchy FP;Moyer KL;Frederick RO;Tonelli M;Aceti DJ;Palmenberg AC;Markley JL |
View
More |
| 25259514
|
Synthesis and evaluation of 9-deoxy analogues of (-)-thysanone, an inhibitor of HRV 3C protease. |
Eur J Med Chem |
2014 |
Young Jeong J;Sperry J;Taylor JA;Brimble MA |
View
More |
| 25261311
|
Proteases of human rhinovirus: role in infection. |
Methods Mol Biol |
2015 |
Jensen LM;Walker EJ;Jans DA;Ghildyal R |
View
More |
| 25261312
|
A protocol to express and isolate HRV16 3C protease for use in protease assays. |
Methods Mol Biol |
2015 |
Jensen LM;Walker EJ;Ghildyal R |
View
More |
| 25261314
|
Reverse genetic engineering of the human rhinovirus serotype 16 genome to introduce an antibody-detectable tag. |
Methods Mol Biol |
2015 |
Walker EJ;Jensen LM;Ghildyal R |
View
More |
| 25350699
|
Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting. |
Bioconjug Chem |
2014 |
Stefan N;Zimmermann M;Simon M;Zangemeister-Wittke U;Pluckthun A |
View
More |
| 2546760
|
The expression and purification of human rhinovirus protease 3C. |
Eur J Biochem |
1989 |
Knott JA;Orr DC;Montgomery DS;Sullivan CA;Weston A |
View
More |
| 2555433
|
Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli. |
J Gen Virol |
1989 |
Orr DC;Long AC;Kay J;Dunn BM;Cameron JM |
View
More |
| 2555540
|
Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. |
J Virol |
1989 |
Cordingley MG;Register RB;Callahan PL;Garsky VM;Colonno RJ |
View
More |
| 2556299
|
A consensus sequence for substrate hydrolysis by rhinovirus 3C proteinase. |
FEBS Lett |
1989 |
Long AC;Orr DC;Cameron JM;Dunn BM;Kay J |
View
More |
| 25792507
|
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study. |
J Enzyme Inhib Med Chem |
2016 |
Ang MJ;Lau QY;Ng FM;Then SW;Poulsen A;Cheong YK;Ngoh ZX;Tan YW;Peng J;Keller TH;Hill J;Chu JJ;Chia CS |
View
More |
| 27093053
|
Activity of the Human Rhinovirus 3C Protease Studied in Various Buffers, Additives and Detergents Solutions for Recombinant Protein Production. |
PLoS One |
2016 |
Ullah R;Shah MA;Tufail S;Ismat F;Imran M;Iqbal M;Mirza O;Rhaman M |
View
More |
| 27105777
|
A dual protease approach for expression and affinity purification of recombinant proteins. |
Anal Biochem |
2016 |
Raran-Kurussi S;Waugh DS |
View
More |
| 27265257
|
Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2016 |
Kawatkar SP;Gagnon M;Hoesch V;Tiong-Yip C;Johnson K;Ek M;Nilsson E;Lister T;Olsson L;Patel J;Yu Q |
View
More |
| 27645381
|
Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease. |
Sci Rep |
2016 |
Tan YW;Ang MJ;Lau QY;Poulsen A;Ng FM;Then SW;Peng J;Hill J;Hong WJ;Chia CS;Chu JJ |
View
More |
| 27681132
|
Rhinovirus 16 2A Protease Affects Nuclear Localization of 3CD during Infection. |
J Virol |
2016 |
Walker E;Jensen L;Croft S;Wei K;Fulcher AJ;Jans DA;Ghildyal R |
View
More |
| 28179529
|
Differential Disruption of Nucleocytoplasmic Trafficking Pathways by Rhinovirus 2A Proteases. |
J Virol |
2017 |
Watters K;Inankur B;Gardiner JC;Warrick J;Sherer NM;Yin J;Palmenberg AC |
View
More |
| 28217559
|
A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity. |
Front Cell Infect Microbiol |
2017 |
Li B;Yue Y;Zhang Y;Yuan Z;Li P;Song N;Lin W;Liu Y;Gu L;Meng H |
View
More |
| 2845133
|
Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. |
J Virol |
1988 |
Lloyd RE;Grubman MJ;Ehrenfeld E |
View
More |
| 28778471
|
Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2017 |
Zhang Q;Cao R;Liu A;Lei S;Li Y;Yang J;Li S;Xiao J |
View
More |
| 28801725
|
Optimization of Soluble Expression and Purification of Recombinant Human Rhinovirus Type-14 3C Protease Using Statistically Designed Experiments: Isolation and Characterization of the Enzyme. |
Mol Biotechnol |
2017 |
Antoniou G;Papakyriacou I;Papaneophytou C |
View
More |
| 28843814
|
Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection. |
Virology |
2017 |
Aumayr M;Schrempf A;Uzulmez O;Olek KM;Skern T |
View
More |
| 29371673
|
Human Rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation. |
Sci Rep |
2018 |
Croft SN;Walker EJ;Ghildyal R |
View
More |
| 29433930
|
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2018 |
Namoto K;Sirockin F;Sellner H;Wiesmann C;Villard F;Moreau RJ;Valeur E;Paulding SC;Schleeger S;Schipp K;Loup J;Andrews L;Swale R;Robinson M;Farady CJ |
View
More |
| 29449668
|
Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death. |
Cell Death Dis |
2018 |
Lotzerich M;Roulin PS;Boucke K;Witte R;Georgiev O;Greber UF |
View
More |
| 29530860
|
Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro. |
Antimicrob Agents Chemother |
2018 |
Kitano M;Hosmillo M;Emmott E;Lu J;Goodfellow I |
View
More |
| 29633974
|
Structural view of the 2A protease from human rhinovirus C15. |
Acta Crystallogr F Struct Biol Commun |
2018 |
Ling H;Yang P;Hou H;Sun Y |
View
More |
| 29866517
|
Identification of quinone analogues as potential inhibitors of picornavirus 3C protease in vitro. |
Bioorg Med Chem Lett |
2018 |
Jung E;Lee JY;Kim HJ;Ryu CK;Lee KI;Kim M;Lee CK;Go YY |
View
More |
| 29980604
|
Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways. |
Clin Sci (Lond) |
2018 |
Dimasuay KG;Sanchez A;Schaefer N;Polanco J;Ferrington DA;Chu HW |
View
More |
| 30074003
|
Subclinical atherosclerosis and impaired cardiac autonomic control in pediatric patients with Vitamin B12 deficiency. |
Niger J Clin Pract |
2018 |
Celik SF;Celik E |
View
More |
| 30118570
|
Building and Breaking Bonds via a Compact S-Propargyl-Cysteine to Chemically Control Enzymes and Modify Proteins. |
Angew Chem Int Ed Engl |
2018 |
Liu J;Cheng R;Wu H;Li S;Wang PG;DeGrado WF;Rozovsky S;Wang L |
View
More |
| 30352199
|
Development of a homogeneous time-resolved fluorescence assay for detection of viral double-stranded RNA. |
Anal Biochem |
2019 |
Fujita M;Adachi K;Nagasawa M |
View
More |
| 30461192
|
Toward development of generic inhibitors against the 3C proteases of picornaviruses. |
FEBS J |
2019 |
Banerjee K;Bhat R;Rao VUB;Nain A;Rallapalli KL;Gangopadhyay S;Singh RP;Banerjee M;Jayaram B |
View
More |
| 30646829
|
Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. |
J Biomol Struct Dyn |
2020 |
Jain S;Amin SA;Adhikari N;Jha T;Gayen S |
View
More |
| 30686346
|
A simplified method to remove fusion tags from a xylanase of Bacillus sp. HBP8 with HRV 3C protease. |
Enzyme Microb Technol |
2019 |
Xu H;Wang Q;Zhang Z;Yi L;Ma L;Zhai C |
View
More |
| 30802413
|
A General Guide for the Optimization of Enzyme Assay Conditions Using the Design of Experiments Approach. |
SLAS Discov |
2019 |
Onyeogaziri FC;Papaneophytou C |
View
More |
| 30844608
|
New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling. |
Eur J Med Chem |
2019 |
Kassem AF;Batran RZ;Abbas EMH;Elseginy SA;Shaheen MNF;Elmahdy EM |
View
More |
| 30868206
|
Soluble expression of IGF1 fused to DsbA in SHuffle T7 strain: optimization of expression and purification by Box-Behnken design. |
Appl Microbiol Biotechnol |
2019 |
Emamipour N;Vossoughi M;Mahboudi F;Golkar M;Fard-Esfahani P |
View
More |
| 31085771
|
N-acetylcysteine with low-dose estrogen reduces cardiac ischemia-reperfusion injury. |
J Endocrinol |
2019 |
Sivasinprasasn S;Palee S;Chattipakorn K;Jaiwongkum T;Apaijai N;Pratchayasakul W;Chattipakorn SC;Chattipakorn N |
View
More |
| 31117169
|
Design of a Human Rhinovirus-14 3C Protease-Inducible Caspase-3. |
Molecules |
2019 |
Wagner HJ;Weber W |
View
More |
| 31612259
|
Using the IPTG-Inducible Pgrac212 Promoter for Overexpression of Human Rhinovirus 3C Protease Fusions in the Cytoplasm of Bacillus subtilis Cells. |
Curr Microbiol |
2019 |
Le VD;Phan TTP;Nguyen TM;Brunsveld L;Schumann W;Nguyen HD |
View
More |
| 31613083
|
Quantitative Analysis of the Substrate Specificity of Human Rhinovirus 3C Protease and Exploration of Its Substrate Recognition Mechanisms. |
ACS Chem Biol |
2020 |
Fan X;Li X;Zhou Y;Mei M;Liu P;Zhao J;Peng W;Jiang ZB;Yang S;Iverson BL;Zhang G;Yi L |
View
More |
| 32339852
|
Exposure to acrylamide and reduced heart rate variability: The mediating role of transforming growth factor-beta. |
J Hazard Mater |
2020 |
Wang B;Cheng M;Yang S;Qiu W;Li W;Zhou Y;Wang X;Yang M;He H;Zhu C;Cen X;Chen A;Xiao L;Zhou M;Ma J;Mu G;Wang D;Guo Y;Zhang X;Chen W |
View
More |
| 32467165
|
Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses. |
Proc Natl Acad Sci U S A |
2020 |
Meng B;Lan K;Xie J;Lerner RA;Wilson IA;Yang B |
View
More |
| 32547310
|
N-acetylcysteine Restored Heart Rate Variability and Prevented Serious Adverse Events in Transfusion-dependent Thalassemia Patients: a Double-blind Single Center Randomized Controlled Trial. |
Int J Med Sci |
2020 |
Pattanakuhar S;Phrommintikul A;Tantiworawit A;Srichairattanakool S;Chattipakorn SC;Chattipakorn N |
View
More |
| 32695242
|
Plasma Homocysteine and Autonomic Nervous Dysfunction: Association and Clinical Relevance in OSAS. |
Dis Markers |
2020 |
Liu L;Wu Q;Yan H;Zheng X;Zhou Q |
View
More |
| 33093214
|
Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia. |
Science |
2020 |
Robinson KS;Teo DET;Tan KS;Toh GA;Ong HH;Lim CK;Lay K;Au BV;Lew TS;Chu JJH;Chow VTK;Wang Y;Zhong FL;Reversade B |
View
More |
| 33166527
|
NT*-HRV3CP: An optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage. |
J Biotechnol |
2021 |
Abdelkader EH;Otting G |
View
More |
| 33357221
|
Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts. |
BMC Complement Med Ther |
2020 |
Walther C;Doring K;Schmidtke M |
View
More |
| 33872498
|
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2. |
J Med Chem |
2022 |
Dai W;Jochmans D;Xie H;Yang H;Li J;Su H;Chang D;Wang J;Peng J;Zhu L;Nian Y;Hilgenfeld R;Jiang H;Chen K;Zhang L;Xu Y;Neyts J;Liu H |
View
More |
| 34077853
|
A CDR-based approach to generate covalent inhibitory antibody for human rhinovirus protease. |
Bioorg Med Chem |
2021 |
Cheng Y;Wu J;Han Y;Xu J;Da Y;Zhao Q;Guo G;Zhou Y;Chen Y;Liu J;Chen H;Jiang X;Cai X |
View
More |
| 34285133
|
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. |
Science |
2021 |
Drayman N;DeMarco JK;Jones KA;Azizi SA;Froggatt HM;Tan K;Maltseva NI;Chen S;Nicolaescu V;Dvorkin S;Furlong K;Kathayat RS;Firpo MR;Mastrodomenico V;Bruce EA;Schmidt MM;Jedrzejczak R;Munoz-Alia MA;Schuster B;Nair V;Han KY;O'Brien A;Tomatsidou A;Meyer B;Vignuzzi M;Missiakas D;Botten JW;Brooke CB;Lee H;Baker SC;Mounce BC;Heaton NS;Severson WE;Palmer KE;Dickinson BC;Joachimiak A;Randall G;Tay S |
View
More |
| 34315103
|
Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk. |
Virology |
2021 |
Deutschmann-Olek KM;Yue WW;Bezerra GA;Skern T |
View
More |
| 34506130
|
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode. |
Biochemistry |
2021 |
Lockbaum GJ;Henes M;Lee JM;Timm J;Nalivaika EA;Thompson PR;Kurt Yilmaz N;Schiffer CA |
View
More |
| 35642592
|
In vivo enzymatic digestion of HRV 3C protease cleavage sites-containing proteins produced in a silkworm-baculovirus expression system. |
Biosci Rep |
2022 |
Xu J;Nakanishi T;Kato T;Park EY |
View
More |
| 36860857
|
Hydrogen peroxide attenuates rhinovirus-induced anti-viral interferon secretion in sinonasal epithelial cells. |
Front Immunol |
2023 |
Lee SH;Han MS;Lee TH;Lee DB;Park JH;Lee SH;Kim TH |
View
More |
| 7478993
|
Picornavirus internal ribosome entry segments: comparison of translation efficiency and the requirements for optimal internal initiation of translation in vitro. |
Nucleic Acids Res |
1995 |
Borman AM;Bailly JL;Girard M;Kean KM |
View
More |
| 7491779
|
Picornavirus 2A proteinase-mediated stimulation of internal initiation of translation is dependent on enzymatic activity and the cleavage products of cellular proteins. |
Virology |
1995 |
Ziegler E;Borman AM;Deliat FG;Liebig HD;Jugovic D;Kean KM;Skern T;Kuechler E |
View
More |
| 7494250
|
Analysis of picornavirus 2A(pro) proteins: separation of proteinase from translation and replication functions. |
J Virol |
1995 |
Lu HH;Li X;Cuconati A;Wimmer E |
View
More |
| 7515772
|
Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. |
Cell |
1994 |
Matthews DA;Smith WW;Ferre RA;Condon B;Budahazi G;Sisson W;Villafranca JE;Janson CA;McElroy HE;Gribskov CL;et al. |
View
More |
| 7645249
|
Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4. |
Virology |
1995 |
Joachims M;Harris KS;Etchison D |
View
More |
| 7665619
|
Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. |
J Biol Chem |
1995 |
Lamphear BJ;Kirchweger R;Skern T;Rhoads RE |
View
More |
| 7745693
|
Foot-and-mouth disease virus Lb proteinase can stimulate rhinovirus and enterovirus IRES-driven translation and cleave several proteins of cellular and viral origin. |
J Virol |
1995 |
Ziegler E;Borman AM;Kirchweger R;Skern T;Kean KM |
View
More |
| 7745714
|
Interaction between the 5\'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. |
J Virol |
1995 |
Xiang W;Harris KS;Alexander L;Wimmer E |
View
More |
| 7765405
|
A high capacity microbial screen for inhibitors of human rhinovirus protease 3C. |
Biotechnology (N Y) |
1994 |
McCall JO;Kadam S;Katz L |
View
More |
| 7782313
|
Sequence and structural determinants of the interaction between the 5\'-noncoding region of picornavirus RNA and rhinovirus protease 3C. |
J Biol Chem |
1995 |
Walker PA;Leong LE;Porter AG |
View
More |
| 7794931
|
Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase. |
Biochemistry |
1995 |
Malcolm BA;Lowe C;Shechosky S;McKay RT;Yang CC;Shah VJ;Simon RJ;Vederas JC;Santi DV |
View
More |
| 7941352
|
The 2A proteinase of human rhinovirus is a zinc containing enzyme. |
Virology |
1994 |
Sommergruber W;Casari G;Fessl F;Seipelt J;Skern T |
View
More |
| 8071130
|
Citrinin hydrate and radicinin: human rhinovirus 3C-protease inhibitors discovered in a target-directed microbial screen. |
J Antibiot (Tokyo) |
1994 |
Kadam S;Poddig J;Humphrey P;Karwowski J;Jackson M;Tennent S;Fung L;Hochlowski J;Rasmussen R;McAlpine J |
View
More |
| 8164744
|
Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. |
Nature |
1994 |
Allaire M;Chernaia MM;Malcolm BA;James MN |
View
More |
| 8245010
|
Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5\'-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities. |
J Biol Chem |
1993 |
Leong LE;Walker PA;Porter AG |
View
More |
| 8291255
|
2A proteinases of coxsackie- and rhinovirus cleave peptides derived from eIF-4 gamma via a common recognition motif. |
Virology |
1994 |
Sommergruber W;Ahorn H;Klump H;Seipelt J;Zoephel A;Fessl F;Krystek E;Blaas D;Kuechler E;Liebig HD;et al. |
View
More |
| 8320292
|
Structural and mechanistic aspects of 3C proteases from the Picornavirus family. |
J Chem Inf Comput Sci |
1993 |
Arad D;Kreisberg R;Shokhen M |
View
More |
| 8338854
|
Purification of two picornaviral 2A proteinases: interaction with eIF-4 gamma and influence on in vitro translation. |
Biochemistry |
1993 |
Liebig HD;Ziegler E;Yan R;Hartmuth K;Klump H;Kowalski H;Blaas D;Sommergruber W;Frasel L;Lamphear B;et al. |
View
More |
| 8392608
|
Inhibition of proteolytic activity of poliovirus and rhinovirus 2A proteinases by elastase-specific inhibitors. |
J Virol |
1993 |
Molla A;Hellen CU;Wimmer E |
View
More |
| 8396129
|
Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. |
J Biol Chem |
1993 |
Lamphear BJ;Yan R;Yang F;Waters D;Liebig HD;Klump H;Kuechler E;Skern T;Rhoads RE |
View
More |
| 8520469
|
The picornaviral 3C proteinases: cysteine nucleophiles in serine proteinase folds. |
Protein Sci |
1995 |
Malcolm BA |
View
More |
| 8535153
|
Purification of recombinant human rhinovirus 14 3C protease expressed in Escherichia coli. |
Protein Expr Purif |
1995 |
Birch GM;Black T;Malcolm SK;Lai MT;Zimmerman RE;Jaskunas SR |
View
More |
| 8580843
|
Spectroscopic characterization of rhinoviral protease 2A: Zn is essential for the structural integrity. |
Protein Sci |
1995 |
Voss T;Meyer R;Sommergruber W |
View
More |
| 8659103
|
Proteolytically active 2A proteinase of human rhinovirus 2 is toxic for Saccharomyces cerevisiae but does not cleave the homologues of eIF-4 gamma in vivo or in vitro. |
Virology |
1996 |
Klump H;Auer H;Liebig HD;Kuechler E;Skern T |
View
More |
| 8761474
|
Human rhinovirus 2A proteinase mutant and its second-site revertants. |
Biochem J |
1996 |
Luderer-Gmach M;Liebig HD;Sommergruber W;Voss T;Fessl F;Skern T;Kuechler E |
View
More |
| 8787922
|
Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases. |
Antimicrob Agents Chemother |
1996 |
Heinz BA;Tang J;Labus JM;Chadwell FW;Kaldor SW;Hammond M |
View
More |
| 8961935
|
A single amino acid change in protein synthesis initiation factor 4G renders cap-dependent translation resistant to picornaviral 2A proteases. |
Biochemistry |
1996 |
Lamphear BJ;Rhoads RE |
View
More |
| 8970966
|
The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. |
J Virol |
1996 |
Haghighat A;Svitkin Y;Novoa I;Kuechler E;Skern T;Sonenberg N |
View
More |
| 8972564
|
Mengo virus 3C proteinase: recombinant expression, intergenus substrate cleavage and localization in vivo. |
Virus Genes |
1996 |
Hall DJ;Palmenberg AC |
View
More |
| 8978838
|
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. |
J Med Chem |
1996 |
Webber SE;Tikhe J;Worland ST;Fuhrman SA;Hendrickson TF;Matthews DA;Love RA;Patick AK;Meador JW;Ferre RA;Brown EL;DeLisle DM;Ford CE;Binford SL |
View
More |
| 9023100
|
Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. |
Nucleic Acids Res |
1997 |
Borman AM;Le Mercier P;Girard M;Kean KM |
View
More |
| 9207196
|
Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates. |
Biochem Biophys Res Commun |
1997 |
Wang QM;Sommergruber W;Johnson RB |
View
More |
| 9268151
|
Mutational analyses support a model for the HRV2 2A proteinase. |
Virology |
1997 |
Sommergruber W;Seipelt J;Fessl F;Skern T;Liebig HD;Casari G |
View
More |
| 9328292
|
Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase. |
Arch Biochem Biophys |
1997 |
Davis GJ;Wang QM;Cox GA;Johnson RB;Wakulchik M;Dotson CA;Villarreal EC |
View
More |
| 9344409
|
A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. |
Anal Biochem |
1997 |
Wang QM;Johnson RB;Cox GA;Villarreal EC;Loncharich RJ |
View
More |
| 9445078
|
Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. |
J Virol |
1998 |
Wang QM;Johnson RB;Cox GA;Villarreal EC;Churgay LM;Hale JE |
View
More |
| 9472614
|
A structural model of picornavirus leader proteinases based on papain and bleomycin hydrolase. |
J Gen Virol |
1998 |
Skern T;Fita I;Guarne A |
View
More |
| 9636362
|
The predominant elF4G-specific cleavage activity in poliovirus-infected HeLa cells is distinct from 2A protease. |
Virology |
1998 |
Bovee ML;Marissen WE;Zamora M;Lloyd RE |
View
More |
| 9636363
|
Direct cleavage of elF4G by poliovirus 2A protease is inefficient in vitro. |
Virology |
1998 |
Bovee ML;Lamphear BJ;Rhoads RE;Lloyd RE |
View
More |
| 9651162
|
Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. |
J Med Chem |
1998 |
Kong JS;Venkatraman S;Furness K;Nimkar S;Shepherd TA;Wang QM;Aube J;Hanzlik RP |
View
More |
| 9667969
|
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. |
J Med Chem |
1998 |
Webber SE;Okano K;Little TL;Reich SH;Xin Y;Fuhrman SA;Matthews DA;Love RA;Hendrickson TF;Patick AK;Meador JW 3rd;Ferre RA;Brown EL;Ford CE;Binford SL;Worland ST |
View
More |
| 9667970
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Reich SH;Prins TJ;Marakovits JT;Littlefield ES;Zhou R;Tikhe J;Ford CE;Wallace MB;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;Harr JE;DeLisle DM;Worland ST |
View
More |
| 9667971
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Reich SH;Marakovits JT;Prins TJ;Zhou R;Tikhe J;Littlefield ES;Bleckman TM;Wallace MB;Little TL;Ford CE;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;DeLisle DM;Worland ST |
View
More |
| 9681985
|
Development of in vitro peptide substrates for human rhinovirus-14 2A protease. |
Arch Biochem Biophys |
1998 |
Wang QM;Johnson RB;Sommergruber W;Shepherd TA |
View
More |
| 9755863
|
Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. |
FEBS Lett |
1998 |
Ventoso I;MacMillan SE;Hershey JW;Carrasco L |
View
More |
| 9847377
|
Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: another mechanism for host protein synthesis shutoff? |
J Virol |
1999 |
Kerekatte V;Keiper BD;Badorff C;Cai A;Knowlton KU;Rhoads RE |
View
More |
| 9895238
|
The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. |
Free Radic Biol Med |
1999 |
Biagioli MC;Kaul P;Singh I;Turner RB |
View
More |
| 9989947
|
Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides. |
Arch Biochem Biophys |
1999 |
Kati WM;Sham HL;McCall JO;Montgomery DA;Wang GT;Rosenbrook W;Miesbauer L;Buko A;Norbeck DW |
View
More |
